Form 4: Eliem Therapeutics EVP Valerie Morisset Sells 50,000 Shares
SEC Form 4
Valerie Morisset, EVP, R&D and CSO of Eliem Therapeutics, Inc., sold 50,000 shares of common stock on July 16, 2024, at a price of $7.13 per share.
Summary
- On July 16, 2024, Valerie Morisset, the EVP, R&D and CSO of Eliem Therapeutics, Inc. (ELYM), sold 50,000 shares of the company's common stock.
- The sale was executed at a price of $7.13 per share.
- Following the transaction, Morisset directly owns 202,306 shares of Eliem Therapeutics.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but the market may interpret the sale in various ways.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. They can be driven by a variety of factors, including personal financial planning or diversification strategies. It's important to consider the context of the sale, such as the overall trading volume and the executive's remaining holdings, to assess its potential impact.
Stakeholder Impact
- Shareholders may react to the stock sale, potentially influencing the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 07/16/2024 | Date of the stock sale transaction. |
| 07/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.